{"title":"一项前瞻性、随机、开放标签、国际多中心、III期、非劣效性试验的可行性,以评估主动监测低风险导管原位癌的安全性——LORD研究","authors":"L.J. Solin MD, FACR, FASTRO","doi":"10.1016/j.breastdis.2016.01.009","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":9266,"journal":{"name":"Breast Diseases: A Year Book Quarterly","volume":"27 1","pages":"Pages 47-48"},"PeriodicalIF":0.0000,"publicationDate":"2016-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.breastdis.2016.01.009","citationCount":"0","resultStr":"{\"title\":\"Feasibility of a prospective, randomised, open-label, international multicentre, phase III, non-inferiority trial to assess the safety of active surveillance for low risk ductal carcinoma in situ – The LORD study\",\"authors\":\"L.J. Solin MD, FACR, FASTRO\",\"doi\":\"10.1016/j.breastdis.2016.01.009\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":9266,\"journal\":{\"name\":\"Breast Diseases: A Year Book Quarterly\",\"volume\":\"27 1\",\"pages\":\"Pages 47-48\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2016-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/j.breastdis.2016.01.009\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Breast Diseases: A Year Book Quarterly\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1043321X16000102\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Breast Diseases: A Year Book Quarterly","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1043321X16000102","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Feasibility of a prospective, randomised, open-label, international multicentre, phase III, non-inferiority trial to assess the safety of active surveillance for low risk ductal carcinoma in situ – The LORD study